Market Cap 819.46M
Revenue (ttm) 403.14M
Net Income (ttm) -22.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.63%
Debt to Equity Ratio -0.50
Volume 59,090,402
Avg Vol 17,213,020
Day's Range N/A - N/A
Shares Out 257.69M
Stochastic %K 75%
Beta 1.07
Analysts Hold
Price Target $2.97

Company Profile

Esperion Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia cardiovascular disease who...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 734 887 3903
Address:
3891 Ranchero Drive, Suite 150, Ann Arbor, United States
HowDidThatGetInThere
HowDidThatGetInThere Aug. 18 at 4:16 PM
$ESPR Wonder how much Sheldon made on this aquisition.
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 2:19 PM
$ESPR GUTS lol still not there. Many thought they would, but almost all can't. Back to your cube lol
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 12:24 AM
$ESPR Hows the cube working. Post more pictures...Why no derogatory words about the C suite. Come find me, I'll send the address
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 5:52 AM
$ESPR Wonder what DJ looks like…will he be crying in the photo
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 1:12 AM
$ESPR Even more accounts deleted. X accounts nuked too, some abandoned from our request. Run, but can’t hide
0 · Reply
Enjoyycall
Enjoyycall Aug. 11 at 1:11 PM
$ESPR This is how it’s done.
0 · Reply
Gregg617notEsprguy
Gregg617notEsprguy Aug. 10 at 10:26 PM
0 · Reply
OldManLogan
OldManLogan Aug. 9 at 1:00 AM
$ARDX If anyone wants to know what I mean by creating phantom premium, go look at the $ESPR chart... no one can do Phantom premium like Sheldon, but Raab has probably knocked us back enough that a $9 BO is going to feel glorious, even though the stock could be worth $15-20 in a year or two with proper opex management... stock is now ripe for an activist.
2 · Reply
Enjoyycall
Enjoyycall Aug. 7 at 8:38 PM
$ESPR 💪
0 · Reply
omar_progressivetrading
omar_progressivetrading Aug. 7 at 7:11 PM
$ESPR — Only on Stocktwits!
1 · Reply
Latest News on ESPR
Esperion Therapeutics Transcript: EGM 2026

Jul 8, 2026, 8:00 AM EDT - 6 weeks ago

Esperion Therapeutics Transcript: EGM 2026


Esperion Therapeutics Proxy statement: Proxy filing

Jun 16, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 29, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Transcript: AGM 2026

May 28, 2026, 8:00 AM EDT - 2 months ago

Esperion Therapeutics Transcript: AGM 2026


Esperion Therapeutics Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

Esperion Therapeutics Quarterly report: Q1 2026


Esperion Therapeutics Proxy statement: Proxy filing

May 4, 2026, 8:00 AM EDT - 3 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 3 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

May 1, 2026, 8:00 AM EDT - 3 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion to be Acquired by ARCHIMED

May 1, 2026, 7:00 AM EDT - 3 months ago

Esperion to be Acquired by ARCHIMED

ESPR


Esperion Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 4 months ago

Esperion Therapeutics Proxy statement: Proxy filing


Esperion Therapeutics Earnings Call Transcript: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Esperion Therapeutics Earnings Call Transcript: Q4 2025


Esperion Therapeutics Annual report: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Esperion Therapeutics Annual report: Q4 2025


Esperion Therapeutics Earnings release: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Esperion Therapeutics Earnings release: Q4 2025


Esperion Therapeutics Slides: Q4 2025

Mar 10, 2026, 8:00 AM EDT - 5 months ago

Esperion Therapeutics Slides: Q4 2025


Esperion Therapeutics Slides: Corporate presentation

Mar 9, 2026, 7:00 AM EDT - 5 months ago

Esperion Therapeutics Slides: Corporate presentation


Esperion Therapeutics Transcript: M&A announcement

Mar 3, 2026, 8:00 AM EST - 6 months ago

Esperion Therapeutics Transcript: M&A announcement


Esperion Therapeutics Press release: M&A announcement

Mar 3, 2026, 8:00 AM EST - 6 months ago

Esperion Therapeutics Press release: M&A announcement


Esperion Therapeutics Slides: M&A announcement

Mar 3, 2026, 8:00 AM EST - 6 months ago

Esperion Therapeutics Slides: M&A announcement


Esperion Therapeutics Transcript: KOL Event

Nov 11, 2025, 2:00 PM EST - 10 months ago

Esperion Therapeutics Transcript: KOL Event


Esperion Therapeutics Slides: KOL Event

Nov 11, 2025, 2:00 PM EST - 10 months ago

Esperion Therapeutics Slides: KOL Event


Esperion Therapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Earnings Call Transcript: Q3 2025


Esperion Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Quarterly report: Q3 2025


Esperion Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Earnings release: Q3 2025


Esperion Therapeutics Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Esperion Therapeutics Slides: Q3 2025


Esperion Announces Pricing of Public Offering of Common Stock

Oct 7, 2025, 9:29 PM EDT - 11 months ago

Esperion Announces Pricing of Public Offering of Common Stock

ESPR


Esperion Announces Proposed Public Offering of Common Stock

Oct 7, 2025, 4:01 PM EDT - 11 months ago

Esperion Announces Proposed Public Offering of Common Stock

ESPR


Esperion Therapeutics Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q2 2025


Esperion Therapeutics Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Quarterly report: Q2 2025


Esperion Therapeutics Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings release: Q2 2025


Esperion Therapeutics Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Q2 2025


Esperion Appoints Craig Thompson to Board of Directors

Jul 1, 2025, 8:06 AM EDT - 1 year ago

Esperion Appoints Craig Thompson to Board of Directors

ESPR


Esperion Therapeutics Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q1 2025


Esperion Therapeutics Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Quarterly report: Q1 2025


Esperion Therapeutics Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Earnings release: Q1 2025


Esperion Therapeutics Slides: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Q1 2025


Esperion Therapeutics Transcript: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Transcript: Status Update


Esperion Therapeutics Press release: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Press release: Status Update


Esperion Therapeutics Slides: Status Update

Apr 24, 2025, 9:00 AM EDT - 1 year ago

Esperion Therapeutics Slides: Status Update


Esperion Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Proxy statement: Proxy Filing


Esperion Therapeutics Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Esperion Therapeutics Proxy statement: Proxy Filing


Esperion Appoints Robert E. Hoffman to Board of Directors

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Esperion Appoints Robert E. Hoffman to Board of Directors

ESPR


Esperion Therapeutics Earnings Call Transcript: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q4 2024


Esperion Therapeutics Annual report: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Annual report: Q4 2024


Esperion Therapeutics Earnings release: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings release: Q4 2024


Esperion Therapeutics Slides: Q4 2024

Mar 4, 2025, 8:00 AM EST - 1 year ago

Esperion Therapeutics Slides: Q4 2024


Esperion Therapeutics Transcript: KOL Event

Jan 22, 2025, 12:30 PM EST - 1 year ago

Esperion Therapeutics Transcript: KOL Event


Esperion Therapeutics Slides: KOL Event

Jan 22, 2025, 12:30 PM EST - 1 year ago

Esperion Therapeutics Slides: KOL Event


Esperion Therapeutics Slides: FY 2025

Jan 15, 2025, 6:45 PM EST - 1 year ago

Esperion Therapeutics Slides: FY 2025


Esperion Announces $210 Million Convertible Debt Financing

Dec 13, 2024, 6:00 AM EST - 1 year ago

Esperion Announces $210 Million Convertible Debt Financing

ESPR


Esperion Therapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings Call Transcript: Q3 2024


Esperion Therapeutics Quarterly report: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Quarterly report: Q3 2024


Esperion Therapeutics Earnings release: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Earnings release: Q3 2024


Esperion Therapeutics Slides: Q3 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Esperion Therapeutics Slides: Q3 2024


Esperion Therapeutics Earnings Call Transcript: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Earnings Call Transcript: Q2 2024


Esperion Therapeutics Quarterly report: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Quarterly report: Q2 2024


Esperion Therapeutics Earnings release: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Earnings release: Q2 2024


Esperion Therapeutics Slides: Q2 2024

Aug 12, 2024, 8:00 AM EDT - 2 years ago

Esperion Therapeutics Slides: Q2 2024


Esperion Therapeutics Slides: Corporate Presentation

Aug 8, 2024, 7:00 AM EDT - 2 years ago

Esperion Therapeutics Slides: Corporate Presentation


HowDidThatGetInThere
HowDidThatGetInThere Aug. 18 at 4:16 PM
$ESPR Wonder how much Sheldon made on this aquisition.
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 2:19 PM
$ESPR GUTS lol still not there. Many thought they would, but almost all can't. Back to your cube lol
0 · Reply
Enjoyycall
Enjoyycall Aug. 18 at 12:24 AM
$ESPR Hows the cube working. Post more pictures...Why no derogatory words about the C suite. Come find me, I'll send the address
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 5:52 AM
$ESPR Wonder what DJ looks like…will he be crying in the photo
1 · Reply
Enjoyycall
Enjoyycall Aug. 12 at 1:12 AM
$ESPR Even more accounts deleted. X accounts nuked too, some abandoned from our request. Run, but can’t hide
0 · Reply
Enjoyycall
Enjoyycall Aug. 11 at 1:11 PM
$ESPR This is how it’s done.
0 · Reply
Gregg617notEsprguy
Gregg617notEsprguy Aug. 10 at 10:26 PM
0 · Reply
OldManLogan
OldManLogan Aug. 9 at 1:00 AM
$ARDX If anyone wants to know what I mean by creating phantom premium, go look at the $ESPR chart... no one can do Phantom premium like Sheldon, but Raab has probably knocked us back enough that a $9 BO is going to feel glorious, even though the stock could be worth $15-20 in a year or two with proper opex management... stock is now ripe for an activist.
2 · Reply
Enjoyycall
Enjoyycall Aug. 7 at 8:38 PM
$ESPR 💪
0 · Reply
omar_progressivetrading
omar_progressivetrading Aug. 7 at 7:11 PM
$ESPR — Only on Stocktwits!
1 · Reply
Dave_100
Dave_100 Aug. 6 at 7:50 PM
$ESPR DS sales were flat last quarter too. Maybe I will chalk this one more up to a potential bullet dodged and less of a golden goose stolen out from under everyone. With some hindsight this is feeling more like a case of massive incompetence on the part of the C suite.
2 · Reply
Dave_100
Dave_100 Aug. 6 at 7:46 PM
$ESPR script growth still looks disappointing. So I guess they haven’t flipped the switch yet. Enbumyst is pathetic, still can barely crack 10 scripts per week. Not holding out much hope for the CVRs.
1 · Reply
Enjoyycall
Enjoyycall Aug. 3 at 11:37 PM
0 · Reply
josh23941
josh23941 Aug. 3 at 5:46 PM
0 · Reply
BillyBob1337
BillyBob1337 Jul. 31 at 9:41 PM
$ESPR $DENN same tactic with shorts...thoughts?
0 · Reply
Gregg617notEsprguy
Gregg617notEsprguy Jul. 29 at 3:50 PM
$ESPR posted this a few days ago my new play
2 · Reply
fortyeight
fortyeight Jul. 28 at 7:36 PM
$ESPR Because it has a corrupt BOD.
0 · Reply
Enjoyycall
Enjoyycall Jul. 28 at 2:22 PM
$ESPR Boom, more coming.
0 · Reply
Spaceequiped
Spaceequiped Jul. 27 at 2:26 PM
$ESPR its coming
1 · Reply
Pukkaa56
Pukkaa56 Jul. 27 at 1:25 PM
$ESPR BMEA CRDL OSTX
0 · Reply
Enjoyycall
Enjoyycall Jul. 25 at 5:10 AM
$ESPR when they knock
0 · Reply
Enjoyycall
Enjoyycall Jul. 25 at 4:14 AM
$ESPR “Challenge accepted!” Proceeds to lose for every post till he runs and try’s to hide🫶✈️🇺🇸
1 · Reply